Astellas Enters into Collaborations with PeptiDream and Cullgen to Advance Targeted Protein Degraders
By Ashish Tripathi
Pharma Deals Review: Vol 2023 Issue 8 (Table of Contents)
Published: 8 Aug-2023
DOI: 10.3833/pdr.v2023.i8.2799 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its targeted protein degradation approach, Astellas has entered into a collaboration and licensing agreement with PeptiDream worth up to US$312...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS